This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Alert me to new issues of the journal
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld

A DNA Vaccine for Ebola Virus Is Safe and Immunogenic in a Phase I Clinical Trial
Clin. Vaccine Immunol. Martin et al. 13: 1267

Supplemental material

Files in this Data Supplement:

  • Supplemental file 1 - Table S1 (The median and mean ELISA antibody titers to vaccine antigens), Table S2 (A line listing of the peak ELISA antibody titers against each vaccine antigen for each subject), and Table S3 (The medians, geometric means, and arithmetic means for ELISPOT responses against peptide pools representing each vaccine antigen).
    MS Word document, 86K.



This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Alert me to new issues of the journal
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»